Slideshow

Ultrahigh-Risk Psychosis: Do Things Come in (Omega)-3s?

Author(s):

Brian Miller, MD, PhD, MPH

Can dietary supplementation decrease the risk of transition to psychosis?

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
Meyer
emergency
schizophrenia
sc
schizophrenia
clozapine
brain
cognition
Related Content
Shaheen Lakhan, MD, PhD
June 19th 2025

Marking Progress, Promise of Prescription Digital Therapeutics for Mental Health: Interview with Shaheen Lakhan, MD, PhD

Kenneth J. Bender, PharmD, MA
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
FDA
June 16th 2025

FDA Officially Eliminates Clozapine REMS

Leah Kuntz
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
sleepy somnolence
May 29th 2025

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Leah Kuntz
schizophrenia
May 29th 2025

Positive Phase 2 Results on NBI-1117568 for Schizophrenia Presented at 2025 ASCP Annual Meeting

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.